FIELD: chemistry.
SUBSTANCE: invention concerns gentisic acid salt of amlodipine of the formula 1 . Also the invention concerns a method of obtaining amlodipine gentisate of the formula 1 and a pharmaceutical composition.
EFFECT: gentisic acid salt of amlodipine can be applied in treatment of cardiovascular diseases.
11 cl, 9 ex, 7 tbl
Title | Year | Author | Number |
---|---|---|---|
(S)-(-)-AMLODIPINE CAMSYLATE OR ITS HYDRATE AND PHARMACEUTICAL COMPOSITION INCLUDING THEM | 2007 |
|
RU2403241C1 |
METHOD OF PREPARING CHIRAL AMLODIPINE GENTISATE | 2006 |
|
RU2393150C2 |
AMLODIPINE CAMSYLATE, METHOD FOR ITS PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2002 |
|
RU2241701C1 |
PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING HYPERTENSION | 2011 |
|
RU2571284C2 |
PHARMACEUTICAL COMPOSITION INCLUDING RENIN INHIBITOR, CALCIUM CHANNEL BLOCKER AND DIURETIC | 2003 |
|
RU2316318C2 |
SALT OF ALISKIREN AND SULFURIC ACID | 2007 |
|
RU2439054C2 |
ALISKIREN AND OROTIC ACID SALT | 2007 |
|
RU2456267C2 |
MEDICINAL AGENT FOR TREATMENT OF HYPERTENSION OR HIGH BLOOD PRESSURE | 2010 |
|
RU2539382C2 |
COFORMULATED DRUG FOR CARDIOVASCULAR DISEASES BASED ON CHRONOTHERAPY THERAPY | 2007 |
|
RU2464014C2 |
COMPOSITION INCLUDING AMLODIPINE AND LOSARTAN HAVING IMPROVED STABILITY | 2013 |
|
RU2628538C2 |
Authors
Dates
2008-08-10—Published
2004-12-15—Filed